News about Global Pharma

Spyre Announces First Participants Dosed in Phase 1 Trial of SPY001

Spyre Therapeutics, Inc. announced that it has initiated dosing of healthy volunteers in its first clinical trial of SPY001, an investigational novel half-life extended anti-α4β7 monoclonal antibody.

Global Pharma | 18/06/2024 | By Manvi |  347

Alembic Pharmaceuticals Gets Approval from USFDA for its Injection to Treat Rare Genetic Condition

The US Food & Drug Administration (USFDA) has granted Alembic Pharmaceuticals Limited final clearance for its Abbreviated New Drug Application (ANDA) for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe.

Global Pharma | 18/06/2024 | By Manvi |  239

Lupin Names Abdelaziz Toumi as CEO of its Subsidiary

Lupin has appointed Abdelaziz Toumi (Abdel) as the Chief Executive Officer of its newly formed subsidiary, Lupin Manufacturing Solutions (LMS).

Global Pharma | 18/06/2024 | By Aishwarya |  682

Syntegon Showcases New Settle Plate Changer at ACHEMA 2024

Syntegon has showcased an important new development at ACHEMA 2024 that generated a great deal of interest among pharmaceutical manufacturers: the patented Settle Plate Changer (SPC) for automated viable monitoring in the aseptic filling process.

Global Pharma | 18/06/2024 | By Aishwarya |  731

Takeda Signs Option Deal with Ascentage Pharma to Get Exclusive Global License for Olverembatinib

Takeda has signed an option agreement with Ascentage Pharma to enter into an exclusive license agreement for olverembatinib, an oral, potentially best-in-class, third-generation BCR-ABL tyrosine kinase inhibitor.

Global Pharma | 15/06/2024 | By Aishwarya |  703

Great Point Partners Announces Acquisition of Lyocontract

Great Point Partners (GPP) has acquired Lyocontract GmbH (Lyocontract), a premium independent drug product contract development and manufacturing organization (CDMO) based in Ilsenburg, Germany.

Global Pharma | 15/06/2024 | By Aishwarya |  539

Novavax Submits Application to FDA for Updated JN.1 COVID-19 Vaccine

Novavax, Inc. has submitted an amendment to its Emergency Use Authorization to the US Food and Drug Administration (FDA) for its updated JN.1 COVID-19 vaccine (NVX-CoV2705) for individuals aged 12 and older.

Global Pharma | 15/06/2024 | By Aishwarya |  293

USFDA Grants Approval to Ipsen and Genfit's Drug to Treat Chronic Inflammatory Liver Disease

The French pharmaceutical companies Ipsen and Genfit received fast approval from the US Food and Drug Administration (USFDA) for their medication to treat chronic inflammatory liver disease.

Global Pharma | 14/06/2024 | By Manvi |  560

Bio-Sourcing and Afrigen Biologics to Accelerate Biomanufacturing in South Africa

Bio-Sourcing has signed a partnership agreement with Afrigen Biologics to develop a pilot program in South Africa of a groundbreaking biotherapeutic platform, BioMilk.

Global Pharma | 14/06/2024 | By Aishwarya |  653

Ono Announces Acquisition of Deciphera Pharmaceuticals

Ono Pharmaceutical, Co., Ltd. has completed the tender offer to acquire all outstanding shares of common stock of a US biopharmaceutical company, Deciphera Pharmaceuticals, Inc. for USD 25.60 per share (total amount of approximately USD 2.4 billion) net to the seller in cash.

Global Pharma | 14/06/2024 | By Aishwarya |  790